FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Saturday

 

Health Beat: MS drug banishes symptoms: VIDEO



























For 25 years, Pamela Arterbridge has been building her salon business, one customer at a time.

"I have a dedicated clientele and I never wanted to let them down," Arterbridge said.

But four years ago, she began feeling exhausted and then some symptoms she couldn't ignore.

"I woke up one morning and all of my toes were numb and tingling, and it felt like I had rocks in my shoes," described Arterbridge.

She had MS.

"I have a lesion on my spine, and I have three on my brain," Arterbridge detailed.

Dr. Michael Racke, a neurologist at The Ohio State University's Wexner Medical Center in Columbus, Ohio, is an expert in MS and one of a nationwide team of researchers studying the effects of ocrelizumab.

"Almost half the patients had no evidence of disease activity in terms of their MS," Racke said. "That's much higher than we've seen with any other MS treatment."

Ocrelizumab is also the first drug ever available for the primary, progressive form of the disease, which includes about 15 percent of MS patients. The drug is given to all MS patients as an infusion.

"Patients receive it every six months, certainly a little bit more convenient than a monthly infusion or injection," Racke said.

Arterbridge was on the drug for about a year as part of the clinical trial. She said it's made all the difference.

Story Source: The above story is based on materials provided by 69WFMZTV
Note: Materials may be edited for content and length

Labels: ,



Go to Newer News Go to Older News